Watch this short video to see how SPRYCEL helps to treat Ph+ CML.
Remember, it’s important to take SPRYCEL exactly as prescribed by your doctor.
This is for illustrative purposes only to show how SPRYCEL is thought to work in treating Ph+ CML.
SPRYCEL may cause serious side effects, including low blood cell counts, bleeding problems, fluid retention, heart problems, pulmonary arterial hypertension, severe skin reactions, and tumor lysis syndrome.
Please see detailed Important Facts at the end of this video and the full Prescribing Information by clicking the link below.
Philadelphia chromosome-positive chronic myeloid leukemia, or Ph+ CML, is a type of leukemia or cancer of the blood.
When you have Ph+ CML, an abnormal protein called BCR-ABL causes the bone marrow to produce too many immature or damaged white blood cells.
These damaged white blood cells do not work properly and can crowd out normal white blood cells, red blood cells, and platelets.
SPRYCEL may help to inhibit BCR-ABL.
SPRYCEL works by helping to reduce the number of damaged white blood cells in your body.
This reduction may allow for more normal blood cells to be produced.
It’s important to note that SPRYCEL may cause low red blood cell counts (anemia), low white blood cell counts (neutropenia), and low platelet counts (thrombocytopenia).
Tablets are white to off-white, with “BMS” appearing on one side. These letters may be followed by a number indicating the strength of the tablet, in milligrams. In addition, an identification number will be marked on the other side. Size and shape may vary by dose.
Tablets are taken by mouth.
Pregnant or plan to become pregnant. SPRYCEL® (dasatinib) can harm your unborn baby. You should not become pregnant during treatment with SPRYCEL. If you are able to become pregnant, you should use effective birth control during treatment and for 30 days after your final dose of SPRYCEL. If you become pregnant or think you may be pregnant during treatment with SPRYCEL, talk to your healthcare provider right away.
SPRYCEL may interact with other medicines you are taking. This can change the relative effectiveness of SPRYCEL, or cause unwanted side effects.
SPRYCEL tablets should be stored at room temperature between 68°F to 77°F (20°C to 25°C).
This document has summarized the most important safety information for SPRYCEL. For more in-depth safety information, please read the Patient Information in the full Prescribing Information by clicking the link below.
SPRYCEL may cause low red blood cell counts (anemia), low white blood cell counts (neutropenia), and low platelet counts (thrombocytopenia).
SPRYCEL was studied in people who were newly diagnosed with Ph+ CML in chronic phase—in direct comparison with another TKI called imatinib.